SUBSCRIBE
SUBSCRIBE

Aayushi Pratap and Heather McKenzie

Pictured: The Iovance Cell Therapy Center/courtesy
Drug Development
FDA Approves First One-Time Cell Therapy for a Solid Tumor
On Friday, the regulator greenlit Iovance’s lifileucel to treat advanced melanoma. Prior to the approval, experts told BioSpace that tumor-infiltrating lymphocytes therapies also hold the potential to treat several other solid tumors.
February 12, 2024
 · 
6 min read
 · 
Aayushi Pratap and Heather McKenzie